Tamiflu oseltamivir oral neuraminidase inhibitor regulatory update

The FDA granted marketing approval for the partners' Tamiflu to prevent influenza A and B infection in adults and in adolescents over 13 years old. Tamiflu previously was approved to treat uncomplicat...